| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | serine-type peptidase activity | TMPRSS9 RELN CTRB2 TMPRSS12 CELA3B CELA3A PRSS21 PRSS42P CTRB1 | 2.46e-05 | 207 | 148 | 9 | GO:0008236 |
| GeneOntologyMolecularFunction | serine hydrolase activity | TMPRSS9 RELN CTRB2 TMPRSS12 CELA3B CELA3A PRSS21 PRSS42P CTRB1 | 2.96e-05 | 212 | 148 | 9 | GO:0017171 |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 8.78e-05 | 190 | 148 | 8 | GO:0004252 | |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 1.63e-04 | 3 | 148 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.00e-04 | 18 | 148 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.24e-04 | 4 | 148 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 5.38e-04 | 5 | 148 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 8.03e-04 | 6 | 148 | 2 | GO:0048763 | |
| GeneOntologyBiologicalProcess | proteasome-mediated ubiquitin-dependent protein catabolic process | UBR4 USP25 TBL1XR1 FBXL5 FBXL18 RACK1 SH3RF2 FBXW5 LTN1 AKT1 CDC20 TBL1X FBXW7 | 1.04e-05 | 424 | 146 | 13 | GO:0043161 |
| GeneOntologyBiologicalProcess | proteasomal protein catabolic process | WFS1 UBR4 USP25 TBL1XR1 FBXL5 FBXL18 RACK1 SH3RF2 FBXW5 LTN1 SDF2L1 AKT1 CDC20 TBL1X FBXW7 | 1.24e-05 | 567 | 146 | 15 | GO:0010498 |
| GeneOntologyBiologicalProcess | positive regulation of catabolic process | WFS1 UBR4 TRIM65 ATG2A PTK2 FBXL5 RACK1 SH3RF2 AKT1 AKT2 C4BPA NOCT CDC20 RFPL2 HTT FBXW7 | 3.83e-05 | 701 | 146 | 16 | GO:0009896 |
| Domain | WD40_repeat_dom | WDR33 BCAS3 UBR4 WDR70 NBEA TBL1XR1 ARPC1B WDR74 NWD2 SCAP EML5 RACK1 WDR6 FBXW5 NLE1 WDR90 WDFY3 CDC20 HPS5 WDR62 TBL1X FBXW7 | 1.26e-15 | 297 | 145 | 22 | IPR017986 |
| Domain | WD40 | WDR33 BCAS3 WDR70 NBEA TBL1XR1 ARPC1B WDR74 NWD2 SCAP EML5 RACK1 WDR6 FBXW5 NLE1 WDR90 WDFY3 CDC20 WDR62 TBL1X FBXW7 | 2.39e-14 | 268 | 145 | 20 | SM00320 |
| Domain | WD40_repeat | WDR33 BCAS3 WDR70 NBEA TBL1XR1 ARPC1B WDR74 NWD2 SCAP EML5 RACK1 WDR6 FBXW5 NLE1 WDR90 WDFY3 CDC20 WDR62 TBL1X FBXW7 | 3.16e-14 | 272 | 145 | 20 | IPR001680 |
| Domain | WD_REPEATS_1 | WDR33 BCAS3 WDR70 NBEA TBL1XR1 ARPC1B WDR74 NWD2 SCAP EML5 RACK1 WDR6 FBXW5 NLE1 WDR90 WDFY3 CDC20 WDR62 TBL1X FBXW7 | 4.78e-14 | 278 | 145 | 20 | PS00678 |
| Domain | WD_REPEATS_2 | WDR33 BCAS3 WDR70 NBEA TBL1XR1 ARPC1B WDR74 NWD2 SCAP EML5 RACK1 WDR6 FBXW5 NLE1 WDR90 WDFY3 CDC20 WDR62 TBL1X FBXW7 | 5.12e-14 | 279 | 145 | 20 | PS50082 |
| Domain | WD_REPEATS_REGION | WDR33 BCAS3 WDR70 NBEA TBL1XR1 ARPC1B WDR74 NWD2 SCAP EML5 RACK1 WDR6 FBXW5 NLE1 WDR90 WDFY3 CDC20 WDR62 TBL1X FBXW7 | 5.12e-14 | 279 | 145 | 20 | PS50294 |
| Domain | - | WDR33 BCAS3 WDR70 NBEA TBL1XR1 ARPC1B WDR74 NWD2 SCAP EML5 RACK1 WDR6 FBXW5 NLE1 WDR90 WDFY3 CDC20 HPS5 WDR62 TBL1X FBXW7 | 1.42e-13 | 333 | 145 | 21 | 2.130.10.10 |
| Domain | WD40 | WDR33 BCAS3 WDR70 NBEA TBL1XR1 ARPC1B WDR74 SCAP EML5 RACK1 WDR6 FBXW5 NLE1 WDR90 WDFY3 CDC20 WDR62 TBL1X FBXW7 | 1.51e-13 | 259 | 145 | 19 | PF00400 |
| Domain | WD40/YVTN_repeat-like_dom | WDR33 BCAS3 WDR70 NBEA TBL1XR1 ARPC1B WDR74 NWD2 SCAP EML5 RACK1 WDR6 FBXW5 NLE1 WDR90 WDFY3 CDC20 HPS5 WDR62 TBL1X FBXW7 | 1.59e-13 | 335 | 145 | 21 | IPR015943 |
| Domain | WD40_repeat_CS | WDR70 TBL1XR1 NWD2 SCAP EML5 RACK1 NLE1 WDR90 WDFY3 CDC20 TBL1X FBXW7 | 5.78e-09 | 164 | 145 | 12 | IPR019775 |
| Domain | TRYPSIN_HIS | 1.39e-06 | 103 | 145 | 8 | IPR018114 | |
| Domain | TRYPSIN_SER | 1.73e-06 | 106 | 145 | 8 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.85e-06 | 107 | 145 | 8 | PS00134 | |
| Domain | Peptidase_S1A | 2.80e-06 | 113 | 145 | 8 | IPR001314 | |
| Domain | TRYPSIN_DOM | 3.19e-06 | 115 | 145 | 8 | PS50240 | |
| Domain | Tryp_SPc | 3.63e-06 | 117 | 145 | 8 | SM00020 | |
| Domain | Trypsin_dom | 4.67e-06 | 121 | 145 | 8 | IPR001254 | |
| Domain | Trypsin | 4.67e-06 | 121 | 145 | 8 | PF00089 | |
| Domain | Peptidase_S1_PA | 5.28e-06 | 123 | 145 | 8 | IPR009003 | |
| Domain | TRYPSIN_SER | 6.41e-06 | 90 | 145 | 7 | IPR033116 | |
| Domain | ConA-like_dom | 8.32e-06 | 219 | 145 | 10 | IPR013320 | |
| Domain | Sialidases | 3.72e-05 | 9 | 145 | 3 | IPR011040 | |
| Domain | MIR | 5.28e-05 | 10 | 145 | 3 | PF02815 | |
| Domain | MIR_motif | 5.28e-05 | 10 | 145 | 3 | IPR016093 | |
| Domain | MIR | 5.28e-05 | 10 | 145 | 3 | PS50919 | |
| Domain | MIR | 5.28e-05 | 10 | 145 | 3 | SM00472 | |
| Domain | Quinoprotein_ADH-like_supfam | 5.60e-05 | 53 | 145 | 5 | IPR011047 | |
| Domain | Quinoprot_gluc/sorb_DH | 9.58e-05 | 12 | 145 | 3 | IPR011041 | |
| Domain | HnRNPA1 | 1.79e-04 | 3 | 145 | 2 | IPR021662 | |
| Domain | Ryanodine_rcpt | 1.79e-04 | 3 | 145 | 2 | IPR003032 | |
| Domain | HnRNPA1 | 1.79e-04 | 3 | 145 | 2 | PF11627 | |
| Domain | Ryanrecept_TM4-6 | 1.79e-04 | 3 | 145 | 2 | IPR009460 | |
| Domain | RyR | 1.79e-04 | 3 | 145 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.79e-04 | 3 | 145 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.79e-04 | 3 | 145 | 2 | IPR013333 | |
| Domain | Apc4_WD40_dom | 4.74e-04 | 20 | 145 | 3 | IPR024977 | |
| Domain | ANAPC4_WD40 | 4.74e-04 | 20 | 145 | 3 | PF12894 | |
| Domain | PH_dom-like | AKT3 SPTBN2 PLEKHA4 NBEA PTK2 PLEKHH3 PLEKHG4B MTMR2 AKT1 AKT2 WDFY3 | 5.01e-04 | 426 | 145 | 11 | IPR011993 |
| Domain | G-protein_beta_WD-40_rep | 5.24e-04 | 85 | 145 | 5 | IPR020472 | |
| Domain | SPRY | 5.83e-04 | 87 | 145 | 5 | SM00449 | |
| Domain | DUF4704 | 5.89e-04 | 5 | 145 | 2 | IPR031570 | |
| Domain | Pentaxin_CS | 5.89e-04 | 5 | 145 | 2 | IPR030476 | |
| Domain | DUF4704 | 5.89e-04 | 5 | 145 | 2 | PF15787 | |
| Domain | - | 5.89e-04 | 5 | 145 | 2 | 2.120.10.10 | |
| Domain | FBOX | 7.07e-04 | 52 | 145 | 4 | SM00256 | |
| Domain | SPRY | 8.30e-04 | 94 | 145 | 5 | PF00622 | |
| Domain | SPRY_dom | 8.30e-04 | 94 | 145 | 5 | IPR003877 | |
| Domain | B30.2/SPRY | 8.71e-04 | 95 | 145 | 5 | IPR001870 | |
| Domain | B302_SPRY | 8.71e-04 | 95 | 145 | 5 | PS50188 | |
| Domain | - | 8.71e-04 | 95 | 145 | 5 | 2.60.120.200 | |
| Domain | RIH_assoc-dom | 8.80e-04 | 6 | 145 | 2 | IPR013662 | |
| Domain | PH_BEACH | 8.80e-04 | 6 | 145 | 2 | PF14844 | |
| Domain | Ins145_P3_rec | 8.80e-04 | 6 | 145 | 2 | PF08709 | |
| Domain | RIH_assoc | 8.80e-04 | 6 | 145 | 2 | PF08454 | |
| Domain | RIH_dom | 8.80e-04 | 6 | 145 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.80e-04 | 6 | 145 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.80e-04 | 6 | 145 | 2 | IPR015925 | |
| Domain | - | 8.80e-04 | 6 | 145 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 8.80e-04 | 6 | 145 | 2 | PF01365 | |
| Domain | ARM-type_fold | 1.34e-03 | 339 | 145 | 9 | IPR016024 | |
| Domain | PH-BEACH_dom | 1.63e-03 | 8 | 145 | 2 | IPR023362 | |
| Domain | - | 1.63e-03 | 8 | 145 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.63e-03 | 8 | 145 | 2 | PS51783 | |
| Domain | F-box | 1.83e-03 | 67 | 145 | 4 | PF00646 | |
| Domain | BEACH | 2.08e-03 | 9 | 145 | 2 | PS50197 | |
| Domain | Beach | 2.08e-03 | 9 | 145 | 2 | PF02138 | |
| Domain | - | 2.08e-03 | 9 | 145 | 2 | 1.10.1540.10 | |
| Domain | LisH | 2.08e-03 | 9 | 145 | 2 | PF08513 | |
| Domain | Beach | 2.08e-03 | 9 | 145 | 2 | SM01026 | |
| Domain | PENTAXIN | 2.08e-03 | 9 | 145 | 2 | PS00289 | |
| Domain | BEACH_dom | 2.08e-03 | 9 | 145 | 2 | IPR000409 | |
| Domain | FBOX | 2.38e-03 | 72 | 145 | 4 | PS50181 | |
| Domain | PTX | 2.59e-03 | 10 | 145 | 2 | SM00159 | |
| Domain | F-box_dom | 2.76e-03 | 75 | 145 | 4 | IPR001810 | |
| Domain | Pkinase_C | 2.94e-03 | 37 | 145 | 3 | IPR017892 | |
| Domain | Pentaxin-related | 3.14e-03 | 11 | 145 | 2 | IPR001759 | |
| Domain | Pentaxin | 3.14e-03 | 11 | 145 | 2 | PF00354 | |
| Domain | Pkinase_C | 4.22e-03 | 42 | 145 | 3 | PF00433 | |
| Domain | F-box-like | 4.81e-03 | 44 | 145 | 3 | PF12937 | |
| Domain | ARM-like | 5.20e-03 | 270 | 145 | 7 | IPR011989 | |
| Domain | N2O_reductase_N | 5.88e-03 | 15 | 145 | 2 | IPR011045 | |
| Domain | PH | 6.07e-03 | 278 | 145 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 6.19e-03 | 279 | 145 | 7 | PS50003 | |
| Domain | PH_domain | 6.31e-03 | 280 | 145 | 7 | IPR001849 | |
| Domain | CUB | 6.50e-03 | 49 | 145 | 3 | PF00431 | |
| Domain | GRAM | 6.69e-03 | 16 | 145 | 2 | SM00568 | |
| Domain | CUB | 6.88e-03 | 50 | 145 | 3 | SM00042 | |
| Domain | - | 7.67e-03 | 52 | 145 | 3 | 2.60.120.290 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 2.94e-06 | 15 | 99 | 4 | M47663 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 3.33e-06 | 5 | 99 | 3 | M48999 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 6.62e-06 | 6 | 99 | 3 | M47523 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 1.15e-05 | 7 | 99 | 3 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 1.15e-05 | 7 | 99 | 3 | M47790 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 1.83e-05 | 23 | 99 | 4 | MM15952 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 1.83e-05 | 8 | 99 | 3 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.83e-05 | 8 | 99 | 3 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.83e-05 | 8 | 99 | 3 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 1.83e-05 | 8 | 99 | 3 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.83e-05 | 8 | 99 | 3 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 1.83e-05 | 8 | 99 | 3 | M47803 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 1.83e-05 | 8 | 99 | 3 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.83e-05 | 8 | 99 | 3 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.83e-05 | 8 | 99 | 3 | M47498 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 1.83e-05 | 8 | 99 | 3 | M47715 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 2.18e-05 | 24 | 99 | 4 | M27952 | |
| Pathway | WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN | 2.58e-05 | 25 | 99 | 4 | M39533 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 2.58e-05 | 25 | 99 | 4 | M39384 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 2.74e-05 | 9 | 99 | 3 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 2.74e-05 | 9 | 99 | 3 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 2.74e-05 | 9 | 99 | 3 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 2.74e-05 | 9 | 99 | 3 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 2.74e-05 | 9 | 99 | 3 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 2.74e-05 | 9 | 99 | 3 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 2.74e-05 | 9 | 99 | 3 | M47481 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 2.74e-05 | 9 | 99 | 3 | MM15666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 2.74e-05 | 9 | 99 | 3 | M47972 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 3.89e-05 | 10 | 99 | 3 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 3.89e-05 | 10 | 99 | 3 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 3.89e-05 | 10 | 99 | 3 | M47615 | |
| Pathway | REACTOME_UPTAKE_OF_DIETARY_COBALAMINS_INTO_ENTEROCYTES | 3.89e-05 | 10 | 99 | 3 | M45024 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 3.89e-05 | 10 | 99 | 3 | M27095 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 3.89e-05 | 10 | 99 | 3 | MM14778 | |
| Pathway | WP_FOCAL_ADHESION | 5.05e-05 | 187 | 99 | 8 | MM15913 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 5.32e-05 | 11 | 99 | 3 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 5.32e-05 | 11 | 99 | 3 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 5.32e-05 | 11 | 99 | 3 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 5.32e-05 | 11 | 99 | 3 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 5.32e-05 | 11 | 99 | 3 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 5.32e-05 | 11 | 99 | 3 | M47756 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 5.32e-05 | 11 | 99 | 3 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 5.32e-05 | 11 | 99 | 3 | M47501 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 7.06e-05 | 12 | 99 | 3 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 7.06e-05 | 12 | 99 | 3 | M47798 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 7.06e-05 | 12 | 99 | 3 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 7.06e-05 | 12 | 99 | 3 | M47559 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 7.06e-05 | 12 | 99 | 3 | M45022 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 7.06e-05 | 12 | 99 | 3 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 7.06e-05 | 12 | 99 | 3 | M27939 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 7.06e-05 | 12 | 99 | 3 | MM14777 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 7.06e-05 | 12 | 99 | 3 | MM14550 | |
| Pathway | WP_FOCAL_ADHESION | 7.82e-05 | 199 | 99 | 8 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.82e-05 | 199 | 99 | 8 | M7253 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 9.13e-05 | 13 | 99 | 3 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 9.13e-05 | 13 | 99 | 3 | M47603 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 9.13e-05 | 13 | 99 | 3 | M549 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 1.16e-04 | 14 | 99 | 3 | M47390 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 1.16e-04 | 14 | 99 | 3 | MM15341 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 1.16e-04 | 14 | 99 | 3 | M27638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 1.16e-04 | 14 | 99 | 3 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 1.16e-04 | 14 | 99 | 3 | M47536 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 1.16e-04 | 14 | 99 | 3 | M3862 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 1.44e-04 | 15 | 99 | 3 | M47389 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 1.44e-04 | 15 | 99 | 3 | M26902 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.44e-04 | 15 | 99 | 3 | M47475 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 1.44e-04 | 15 | 99 | 3 | M48306 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 1.44e-04 | 15 | 99 | 3 | M47971 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 1.72e-04 | 40 | 99 | 4 | M39798 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 1.92e-04 | 76 | 99 | 5 | M1749 | |
| Pathway | WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES | 2.13e-04 | 17 | 99 | 3 | M48086 | |
| Pathway | SA_PTEN_PATHWAY | 2.13e-04 | 17 | 99 | 3 | M12771 | |
| Pathway | SA_TRKA_RECEPTOR | 2.13e-04 | 17 | 99 | 3 | M18895 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 2.29e-04 | 43 | 99 | 4 | M39788 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.70e-04 | 302 | 99 | 9 | M39719 | |
| Pathway | WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS | 2.98e-04 | 46 | 99 | 4 | M39805 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 3.00e-04 | 19 | 99 | 3 | M39370 | |
| Pathway | WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS | 3.00e-04 | 19 | 99 | 3 | M39473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 3.00e-04 | 19 | 99 | 3 | M47525 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.07e-04 | 84 | 99 | 5 | M3228 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 3.07e-04 | 84 | 99 | 5 | M39839 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.51e-04 | 48 | 99 | 4 | M611 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | 4.08e-04 | 21 | 99 | 3 | M14966 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 4.08e-04 | 21 | 99 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 4.08e-04 | 21 | 99 | 3 | MM14996 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 4.70e-04 | 22 | 99 | 3 | M13897 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 4.70e-04 | 22 | 99 | 3 | MM15656 | |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 4.70e-04 | 22 | 99 | 3 | M27084 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 4.70e-04 | 22 | 99 | 3 | M47919 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.72e-04 | 326 | 99 | 9 | MM15917 | |
| Pathway | KEGG_MTOR_SIGNALING_PATHWAY | 4.78e-04 | 52 | 99 | 4 | M7561 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 5.37e-04 | 23 | 99 | 3 | M46455 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 5.37e-04 | 23 | 99 | 3 | MM14993 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 5.53e-04 | 54 | 99 | 4 | M42568 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 5.69e-04 | 96 | 99 | 5 | M16121 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 5.69e-04 | 96 | 99 | 5 | M39834 | |
| Pathway | WP_RANKLRANK_SIGNALING | 5.93e-04 | 55 | 99 | 4 | M39667 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 6.11e-04 | 24 | 99 | 3 | M47460 | |
| Pathway | WP_PI3KAKT_SIGNALING | 6.26e-04 | 339 | 99 | 9 | M39736 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 6.91e-04 | 25 | 99 | 3 | M39794 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 17912369 | ||
| Pubmed | Differential activation of AKT isoforms by growth factors in human myotubes. | 8.35e-08 | 3 | 153 | 3 | 37879895 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 21454539 | ||
| Pubmed | Differential prognostic values of the three AKT isoforms in acute myeloid leukemia. | 8.35e-08 | 3 | 153 | 3 | 38528080 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 15987444 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 19825827 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 16540465 | ||
| Pubmed | Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH. | 8.35e-08 | 3 | 153 | 3 | 20102399 | |
| Pubmed | Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. | 8.35e-08 | 3 | 153 | 3 | 18561256 | |
| Pubmed | Differential effects of Akt isoforms on somatic cell reprogramming. | 8.35e-08 | 3 | 153 | 3 | 25037569 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 38396845 | ||
| Pubmed | AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity. | 8.35e-08 | 3 | 153 | 3 | 29173281 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 21590431 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 29235817 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 34296180 | ||
| Pubmed | Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt. | 8.35e-08 | 3 | 153 | 3 | 17982014 | |
| Pubmed | Opposing functions of Akt isoforms in lung tumor initiation and progression. | 8.35e-08 | 3 | 153 | 3 | 24722238 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 24039187 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 16923958 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 17202487 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 26953242 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 23929892 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 19805051 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 25233414 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 21555366 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 32796067 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 25811375 | ||
| Pubmed | Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. | 8.35e-08 | 3 | 153 | 3 | 20724596 | |
| Pubmed | Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS. | 8.35e-08 | 3 | 153 | 3 | 27098694 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 28931550 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 10579998 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 20398329 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 33325370 | ||
| Pubmed | The Akt isoforms are present at distinct subcellular locations. | 8.35e-08 | 3 | 153 | 3 | 20018949 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 24247267 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 17895832 | ||
| Pubmed | Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. | 8.35e-08 | 3 | 153 | 3 | 10491192 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 17210696 | ||
| Pubmed | Role for Akt3/protein kinase Bgamma in attainment of normal brain size. | 8.35e-08 | 3 | 153 | 3 | 15713641 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPHK2 SZT2 BCAS3 UBR4 WDR70 MYOM3 ATG2A ITGB5 PLEKHH3 SCAP GAREM2 LRP3 ULK4 NLE1 AKT1 AKT2 WDR90 WDFY3 BCL2L13 HTT | 9.44e-08 | 1105 | 153 | 20 | 35748872 |
| Pubmed | Composition and Regulation of the Cellular Repertoire of SCF Ubiquitin Ligases. | 3.30e-07 | 62 | 153 | 6 | 29103612 | |
| Pubmed | Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos. | 3.33e-07 | 4 | 153 | 3 | 31552693 | |
| Pubmed | Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. | 3.33e-07 | 4 | 153 | 3 | 19933838 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 21242979 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 19435822 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 21507933 | ||
| Pubmed | Conditional inactivation of Akt three isoforms causes tau hyperphosphorylation in the brain. | 3.33e-07 | 4 | 153 | 3 | 26227811 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 17942896 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 30567482 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 21763505 | ||
| Pubmed | The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. | 8.29e-07 | 5 | 153 | 3 | 20059950 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 9512493 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 27938661 | ||
| Pubmed | Chromosomal assignments of genes for trypsin, chymotrypsin B, and elastase in mouse. | 8.29e-07 | 5 | 153 | 3 | 6589791 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 26855332 | ||
| Pubmed | Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. | 8.29e-07 | 5 | 153 | 3 | 17442925 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 22814751 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 18562319 | ||
| Pubmed | Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. | 8.29e-07 | 5 | 153 | 3 | 19289493 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 20400979 | ||
| Pubmed | Platelet-derived growth factor protects neurons against gp120-mediated toxicity. | 8.29e-07 | 5 | 153 | 3 | 18300076 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 25246356 | ||
| Pubmed | Brown fat organogenesis and maintenance requires AKT1 and AKT2. | 8.29e-07 | 5 | 153 | 3 | 30833219 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 36640312 | ||
| Pubmed | Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. | 8.29e-07 | 5 | 153 | 3 | 26996309 | |
| Pubmed | Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation. | 1.65e-06 | 6 | 153 | 3 | 24642468 | |
| Pubmed | mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis. | 1.65e-06 | 6 | 153 | 3 | 31996678 | |
| Pubmed | KCTD20, a relative of BTBD10, is a positive regulator of Akt. | 1.65e-06 | 6 | 153 | 3 | 24156551 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 14749824 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 23746211 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 12176997 | ||
| Pubmed | Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. | 1.65e-06 | 6 | 153 | 3 | 29038421 | |
| Pubmed | Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. | 1.65e-06 | 6 | 153 | 3 | 10869418 | |
| Pubmed | Akt Regulates Sox10 Expression to Control Oligodendrocyte Differentiation via Phosphorylating FoxO1. | 1.65e-06 | 6 | 153 | 3 | 34385359 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 15616007 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 23673657 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 22107784 | ||
| Pubmed | Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family. | 1.65e-06 | 6 | 153 | 3 | 11707444 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 21606541 | ||
| Pubmed | Protein kinase B alpha/Akt1 regulates placental development and fetal growth. | 1.65e-06 | 6 | 153 | 3 | 12783884 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 18160256 | ||
| Pubmed | AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation. | 1.65e-06 | 6 | 153 | 3 | 17439945 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 20186503 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR4 WDR70 PAPSS2 HNRNPA1 NCAPG2 ARPC1B PTK2 WDR74 CYFIP1 FBXL18 RACK1 WDR6 GLS LTN1 NLE1 MACF1 DDX60L WDFY3 CDC20 TPI1 | 2.22e-06 | 1353 | 153 | 20 | 29467282 |
| Pubmed | NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons. | 2.48e-06 | 22 | 153 | 4 | 21946561 | |
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 23968884 | ||
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 19261608 | ||
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 23604117 | ||
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 23811558 | ||
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 17634444 | ||
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 16287854 | ||
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 17698586 | ||
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 21697490 | ||
| Pubmed | The E3 ligase TRAF6 regulates Akt ubiquitination and activation. | 2.88e-06 | 7 | 153 | 3 | 19713527 | |
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 21295499 | ||
| Pubmed | 4.60e-06 | 8 | 153 | 3 | 16841089 | ||
| Pubmed | 4.60e-06 | 8 | 153 | 3 | 18826950 | ||
| Pubmed | Deletion of Akt1 causes heart defects and abnormal cardiomyocyte proliferation. | 4.60e-06 | 8 | 153 | 3 | 20816796 | |
| Pubmed | 4.60e-06 | 8 | 153 | 3 | 11208609 | ||
| Pubmed | 4.60e-06 | 8 | 153 | 3 | 20040596 | ||
| GeneFamily | WD repeat domain containing | WDR33 BCAS3 WDR70 NBEA TBL1XR1 ARPC1B WDR74 SCAP EML5 RACK1 WDR6 FBXW5 NLE1 WDR90 WDFY3 CDC20 WDR62 TBL1X FBXW7 | 1.01e-16 | 262 | 95 | 19 | 362 |
| GeneFamily | Short pentraxins | 8.17e-05 | 3 | 95 | 2 | 1143 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 8.17e-05 | 3 | 95 | 2 | 287 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.07e-04 | 206 | 95 | 7 | 682 | |
| GeneFamily | Proteases, serine | 3.36e-04 | 63 | 95 | 4 | 738 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 7.49e-04 | 8 | 95 | 2 | 658 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 9.60e-04 | 9 | 95 | 2 | 1230 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 1.46e-03 | 11 | 95 | 2 | 559 | |
| GeneFamily | F-box and leucine rich repeat proteins | 5.38e-03 | 21 | 95 | 2 | 558 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-07 | 168 | 152 | 8 | 8459d0a1bf6d4b5c83001097331f8b78fceb9305 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-07 | 199 | 152 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-06 | 167 | 152 | 7 | a48349f189f6a8d563744b0a294c3974f3a18f50 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 2.90e-06 | 180 | 152 | 7 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-06 | 193 | 152 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-06 | 194 | 152 | 7 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-06 | 194 | 152 | 7 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.42e-06 | 198 | 152 | 7 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 5.79e-06 | 200 | 152 | 7 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | mLN-(6)_Macrophage-(61)_LYVE1_Macrophage|mLN / shred on region, Cell_type, and subtype | 5.79e-06 | 200 | 152 | 7 | a20f5ec61d492d8a2adf695ec304b5d57296aa8f | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|mLN / Region, Cell class and subclass | 5.79e-06 | 200 | 152 | 7 | 89cf739a3c2f5d30e547404f2f2ec6500cd1d65d | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 5.79e-06 | 200 | 152 | 7 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.01e-06 | 138 | 152 | 6 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-05 | 157 | 152 | 6 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-05 | 157 | 152 | 6 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 160 | 152 | 6 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | CV-Mild-4|Mild / Virus stimulation, Condition and Cluster | 1.86e-05 | 160 | 152 | 6 | 2e24f8de5086b086863d3bf4d9afbd9bc93f4d5e | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 161 | 152 | 6 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-1|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.21e-05 | 165 | 152 | 6 | 2ca1154a8692af311d99a4d3aa2f2ac3d23a4310 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Olfr558_(Mural.Rgs5Acta2.Olfr558)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.51e-05 | 101 | 152 | 5 | a05293ccd1de48ed8c7d1417f410d2c4be388c5b | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Olfr558_(Mural.Rgs5Acta2.Olfr558)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.51e-05 | 101 | 152 | 5 | b75b000b7899399d1e6aa692d2a4c33b41a1fe18 | |
| ToppCell | COVID-19_Mild-Neu_2|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 2.80e-05 | 172 | 152 | 6 | f5fd08b42c002d4693646b27e7b708eceb49524f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 174 | 152 | 6 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-05 | 177 | 152 | 6 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 178 | 152 | 6 | b902059c3f861108fc64cbdc05e6f44378f5be2c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-CLDN10+_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 179 | 152 | 6 | 7eca1e19ae6b5b1f18c721691dc3e860705628f2 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 179 | 152 | 6 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | COVID-CD4-CD8_1|COVID / Condition, Cell_class and T cell subcluster | 4.20e-05 | 185 | 152 | 6 | c634bb04a081ae3214b68f6e4a147db5b2b916ed | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-05 | 187 | 152 | 6 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-05 | 189 | 152 | 6 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | ASK454-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.73e-05 | 189 | 152 | 6 | 316c857dec9383823e09f966bca62d52d933b141 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | wk_08-11-Epithelial-PNS-Early_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.87e-05 | 190 | 152 | 6 | 8190674a48607984726974765aafbca116f437e0 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.02e-05 | 191 | 152 | 6 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.17e-05 | 192 | 152 | 6 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.17e-05 | 192 | 152 | 6 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-05 | 193 | 152 | 6 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | Club_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 5.74e-05 | 120 | 152 | 5 | 7f85208f0455f3e634f8e7e81beea60b4ef1d2a5 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.79e-05 | 196 | 152 | 6 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.13e-05 | 198 | 152 | 6 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.13e-05 | 198 | 152 | 6 | dada1c19a261c8e1090957cd7e37f2a43a9fe14f | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 6.30e-05 | 199 | 152 | 6 | 96070b5ffcbab4952970f43b536969ddd2ca5d14 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.30e-05 | 199 | 152 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Transverse-(2)_B_cell-(24)_B_cell_cycling|Transverse / shred on region, Cell_type, and subtype | 6.48e-05 | 200 | 152 | 6 | e3f9736227151f23f0e331eec0a7a15ce464b517 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|Transverse / Region, Cell class and subclass | 6.48e-05 | 200 | 152 | 6 | 0e270f8019d9f22068ca426d661937262a5cd331 | |
| ToppCell | (61)_LYVE1_Macrophage|World / shred on Cell_type and subtype | 7.62e-05 | 206 | 152 | 6 | 711e961a9a03bfd2f0958bd14f25f7f207a2f2b5 | |
| Drug | allysine aldol | 2.78e-06 | 5 | 150 | 3 | CID000191270 | |
| Drug | kazinol B | 4.03e-06 | 17 | 150 | 4 | CID000480869 | |
| Drug | 2-methylproline | 1.53e-05 | 8 | 150 | 3 | CID000095491 | |
| Drug | Akt inhibitor IV | 1.74e-05 | 24 | 150 | 4 | CID002326992 | |
| Drug | T0702 | 2.06e-05 | 25 | 150 | 4 | CID000005908 | |
| Drug | BOCPheONP | 4.31e-05 | 2 | 150 | 2 | CID000111308 | |
| Drug | MPM-06 | 4.31e-05 | 2 | 150 | 2 | CID000161546 | |
| Drug | DEAP-C16Y peptide | 4.31e-05 | 2 | 150 | 2 | ctd:C000609387 | |
| Drug | NSC-374899 | 4.31e-05 | 2 | 150 | 2 | CID000435726 | |
| Drug | methylbenzenebutanoate | 4.31e-05 | 2 | 150 | 2 | CID000281254 | |
| Drug | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | 4.31e-05 | 2 | 150 | 2 | CID004418081 | |
| Drug | c189 | 4.31e-05 | 2 | 150 | 2 | CID000248048 | |
| Drug | dansyl-D-arginine methyl ester | 4.31e-05 | 2 | 150 | 2 | CID000191369 | |
| Drug | methyl 6-phenylhexanoate | 4.31e-05 | 2 | 150 | 2 | CID011820300 | |
| Drug | 5-aminotetrazole | 4.31e-05 | 2 | 150 | 2 | CID000020467 | |
| Drug | 2-bromoisobutyric acid | 4.31e-05 | 2 | 150 | 2 | CID000074924 | |
| Drug | p-toluamidine | 4.31e-05 | 2 | 150 | 2 | CID000122753 | |
| Drug | N-acetyl-alpha-azaphenylalanine phenyl ester | 4.31e-05 | 2 | 150 | 2 | CID000191275 | |
| Drug | isobutyl sulfide | 4.31e-05 | 2 | 150 | 2 | CID000011607 | |
| Drug | LOPAC | 4.34e-05 | 30 | 150 | 4 | CID000062696 | |
| Drug | MMEA | 4.45e-05 | 11 | 150 | 3 | CID000125823 | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 6465_UP | |
| Drug | AC1NUUB8 | 4.96e-05 | 31 | 150 | 4 | CID005493639 | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; HL60; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 2984_DN | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 6248_UP | |
| Drug | Aconitine [302-27-2]; Up 200; 6.2uM; HL60; HG-U133A | 5.39e-05 | 199 | 150 | 8 | 1784_UP | |
| Drug | lercanidipine | 6.00e-05 | 63 | 150 | 5 | CID000065866 | |
| Drug | Thimerosal | AKT3 MCPH1 BCAS3 USP25 TBL1XR1 SAPCD2 ARPC1B PTK2 RYR3 EML5 GAREM2 GLS LTN1 AKT1 WDFY3 IGLON5 TBL1X RAPGEFL1 PGBD2 TPI1 | 1.22e-04 | 1199 | 150 | 20 | ctd:D013849 |
| Drug | flobufen | 1.29e-04 | 3 | 150 | 2 | CID000159476 | |
| Drug | N-acetylbenzotriazole | 1.29e-04 | 3 | 150 | 2 | CID000087784 | |
| Drug | photophor | 1.29e-04 | 3 | 150 | 2 | CID000014780 | |
| Drug | dibutyl iodomethaneboronate | 1.29e-04 | 3 | 150 | 2 | CID000098591 | |
| Drug | zinc;dipicolinate | 1.29e-04 | 3 | 150 | 2 | CID004309911 | |
| Drug | 2-oxobut-3-ynoate | 1.29e-04 | 3 | 150 | 2 | CID000171547 | |
| Drug | cis-diammineplatinum(II | 1.29e-04 | 3 | 150 | 2 | CID000159790 | |
| Drug | AFMeq | 1.29e-04 | 3 | 150 | 2 | CID000194069 | |
| Drug | Bz-Cti-otbu | 1.29e-04 | 3 | 150 | 2 | CID006452691 | |
| Drug | 2-hydroxyheptanoic acid | 1.29e-04 | 3 | 150 | 2 | CID002750949 | |
| Drug | n-(2-oxoethyl)benzamide | 1.29e-04 | 3 | 150 | 2 | CID000188995 | |
| Drug | AC1L49DM | 1.29e-04 | 3 | 150 | 2 | CID000152933 | |
| Drug | c140 | 1.29e-04 | 3 | 150 | 2 | CID002783250 | |
| Drug | 8N3-cADPR | 1.29e-04 | 3 | 150 | 2 | CID000127713 | |
| Drug | Benzamidomethaneboronic acid | 1.29e-04 | 3 | 150 | 2 | CID000127677 | |
| Drug | aminodantrolene | 1.29e-04 | 3 | 150 | 2 | CID009570289 | |
| Drug | phenyl hippurate | 1.29e-04 | 3 | 150 | 2 | CID000076323 | |
| Drug | FK-386 | 1.29e-04 | 3 | 150 | 2 | CID000135044 | |
| Drug | FK-375 | 1.29e-04 | 3 | 150 | 2 | CID000135042 | |
| Drug | carbostyril-124 | 1.29e-04 | 3 | 150 | 2 | CID000088277 | |
| Drug | N-trifluoroacetyl-4-fluorophenylalanine | 1.29e-04 | 3 | 150 | 2 | CID000328214 | |
| Drug | C18 4 | 1.29e-04 | 3 | 150 | 2 | CID000077248 | |
| Drug | 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide | 1.29e-04 | 3 | 150 | 2 | ctd:C548780 | |
| Drug | taraxastane | 1.29e-04 | 3 | 150 | 2 | CID006429404 | |
| Drug | Phe-phe-ome | 1.29e-04 | 3 | 150 | 2 | CID000151728 | |
| Drug | phenylethaneboronic acid | 1.29e-04 | 3 | 150 | 2 | CID000065389 | |
| Drug | 3-amino-2-pyridone | 1.29e-04 | 3 | 150 | 2 | CID000322353 | |
| Drug | ASA-BMPA | 1.29e-04 | 3 | 150 | 2 | CID003035649 | |
| Drug | p-nitrophenyl benzoate | 1.29e-04 | 3 | 150 | 2 | CID000070396 | |
| Drug | Z-Phe-OMe | 1.29e-04 | 3 | 150 | 2 | CID003082435 | |
| Drug | 2-hydroxycarbazole | 1.29e-04 | 3 | 150 | 2 | CID000093551 | |
| Drug | 3-methylcoumarin | 1.29e-04 | 3 | 150 | 2 | CID000017130 | |
| Drug | 2-propyl methylphosphonochloridate | 1.29e-04 | 3 | 150 | 2 | CID000102124 | |
| Drug | FK-316 | 1.29e-04 | 3 | 150 | 2 | CID000133688 | |
| Drug | AC1L19T8 | 1.29e-04 | 3 | 150 | 2 | CID000000694 | |
| Drug | Marinostatin D | 1.29e-04 | 3 | 150 | 2 | CID000132206 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.29e-04 | 3 | 150 | 2 | CID005748312 | |
| Drug | 1FD7 | 1.29e-04 | 3 | 150 | 2 | CID000445579 | |
| Drug | Glt-leu-phe-nh-meq | 1.29e-04 | 3 | 150 | 2 | CID000194914 | |
| Drug | AC1L4Z4F | 1.29e-04 | 3 | 150 | 2 | CID000194913 | |
| Drug | Glt-Phe-NH-FMeq | 1.29e-04 | 3 | 150 | 2 | CID000194912 | |
| Drug | diacetyl trimer | 1.29e-04 | 3 | 150 | 2 | CID000193527 | |
| Drug | FK-448 | 1.29e-04 | 3 | 150 | 2 | CID006917869 | |
| Drug | Ac-Phe-OMe | 1.29e-04 | 3 | 150 | 2 | CID000097805 | |
| Drug | thiobenzyl N-heptafluorobutyrylanthranilate | 1.29e-04 | 3 | 150 | 2 | CID000133906 | |
| Drug | dithiotreitol | VIPR1 SPTBN2 CTRB2 LAMA4 NEU3 PAPSS2 RYR2 RYR3 STK16 NKPD1 CTRB1 | 1.36e-04 | 430 | 150 | 11 | CID000019001 |
| Drug | AC1Q6PMM | 1.38e-04 | 40 | 150 | 4 | CID000003211 | |
| Drug | AC1LAR7G | 1.52e-04 | 41 | 150 | 4 | CID000493598 | |
| Drug | AC1MW7VF | 2.51e-04 | 19 | 150 | 3 | CID000414699 | |
| Drug | Benzoyl-dl-leucine | 2.56e-04 | 4 | 150 | 2 | CID000294887 | |
| Drug | Acafcek | 2.56e-04 | 4 | 150 | 2 | CID000197677 | |
| Drug | B-1,3-od | 2.56e-04 | 4 | 150 | 2 | CID011971053 | |
| Drug | PCB74 | 2.56e-04 | 4 | 150 | 2 | CID000036218 | |
| Drug | AC1Q4I5I | 2.56e-04 | 4 | 150 | 2 | CID000194288 | |
| Drug | dehydromerodesmosine | 2.56e-04 | 4 | 150 | 2 | CID006443540 | |
| Drug | alpha-amyrin palmitate | 2.56e-04 | 4 | 150 | 2 | CID000185477 | |
| Drug | poly-THIQ | 2.56e-04 | 4 | 150 | 2 | CID006453487 | |
| Drug | N-(4-carboxycyclohexylmethyl)-maleimide | 2.56e-04 | 4 | 150 | 2 | CID011548799 | |
| Drug | G2505_sigma | 2.56e-04 | 4 | 150 | 2 | CID000111098 | |
| Drug | p-fluorobenzenesulfonyl chloride | 2.56e-04 | 4 | 150 | 2 | CID000009588 | |
| Drug | BSSDA | 2.56e-04 | 4 | 150 | 2 | CID003081106 | |
| Drug | 148504-47-6 | 2.56e-04 | 4 | 150 | 2 | CID006444275 | |
| Drug | AC1L2HV6 | 2.56e-04 | 4 | 150 | 2 | CID000047328 | |
| Drug | SC 38249 | 2.56e-04 | 4 | 150 | 2 | CID000134834 | |
| Drug | AC1L4X1Z | 2.56e-04 | 4 | 150 | 2 | CID000193815 | |
| Drug | AC1L1U7A | 2.56e-04 | 4 | 150 | 2 | CID000035682 | |
| Drug | NSC-676827 | 2.56e-04 | 4 | 150 | 2 | CID000385555 | |
| Drug | 6-amino-1,2-benzopyrone | 2.56e-04 | 4 | 150 | 2 | CID000046152 | |
| Drug | nitrophenylethanol | 2.56e-04 | 4 | 150 | 2 | CID000097851 | |
| Drug | ATEE | 2.59e-04 | 47 | 150 | 4 | CID000002004 | |
| Drug | 2-nitro-5-thiocyanobenzoic acid | 2.81e-04 | 48 | 150 | 4 | CID000092266 | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; PC3; HT_HG-U133A | 3.09e-04 | 194 | 150 | 7 | 6651_DN | |
| Disease | cancer (implicated_via_orthology) | 8.98e-06 | 268 | 148 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | level of chymotrypsinogen B2 in blood serum | 2.50e-05 | 2 | 148 | 2 | OBA_2041192 | |
| Disease | renal carcinoma (is_marker_for) | 2.50e-05 | 2 | 148 | 2 | DOID:4451 (is_marker_for) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 7.47e-05 | 3 | 148 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 7.47e-05 | 3 | 148 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | chymotrypsinogen B measurement | 7.47e-05 | 3 | 148 | 2 | EFO_0801477 | |
| Disease | sensory system disease (implicated_via_orthology) | 7.47e-05 | 3 | 148 | 2 | DOID:0050155 (implicated_via_orthology) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 1.32e-04 | 20 | 148 | 3 | DOID:2526 (is_implicated_in) | |
| Disease | malignant astrocytoma (is_marker_for) | 2.03e-04 | 23 | 148 | 3 | DOID:3069 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.67e-04 | 195 | 148 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 7.07e-04 | 477 | 148 | 9 | C0005586 | |
| Disease | reticulocyte count | EEF1AKMT4-ECE2 SPHK2 TPCN2 BCAS3 PLEKHA4 LAMA4 TRIM65 ARPC1B STK16 TBC1D8 FBXL18 GLS LTN1 C4BPA | 8.11e-04 | 1045 | 148 | 14 | EFO_0007986 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 8.42e-04 | 145 | 148 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Developmental delay (disorder) | 8.48e-04 | 37 | 148 | 3 | C0424605 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.04e-03 | 152 | 148 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Liver carcinoma | 1.08e-03 | 507 | 148 | 9 | C2239176 | |
| Disease | indoleacetate measurement | 1.10e-03 | 10 | 148 | 2 | EFO_0021015 | |
| Disease | hemoglobin A1 measurement | 1.29e-03 | 520 | 148 | 9 | EFO_0007629 | |
| Disease | response to virus | 1.33e-03 | 11 | 148 | 2 | GO_0009615 | |
| Disease | trypsin-2 measurement | 1.33e-03 | 11 | 148 | 2 | EFO_0008305 | |
| Disease | schizophrenia (is_marker_for) | 1.41e-03 | 44 | 148 | 3 | DOID:5419 (is_marker_for) | |
| Disease | Adenocarcinoma of large intestine | 1.41e-03 | 96 | 148 | 4 | C1319315 | |
| Disease | Mood Disorders | 1.62e-03 | 168 | 148 | 5 | C0525045 | |
| Disease | melanoma | 1.62e-03 | 248 | 148 | 6 | C0025202 | |
| Disease | myopathy (implicated_via_orthology) | 1.81e-03 | 48 | 148 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Drugs used in diabetes use measurement | 1.86e-03 | 255 | 148 | 6 | EFO_0009924 | |
| Disease | intermediate coronary syndrome (is_marker_for) | 1.88e-03 | 13 | 148 | 2 | DOID:8805 (is_marker_for) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.96e-03 | 105 | 148 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Fibrosis | 2.04e-03 | 50 | 148 | 3 | C0016059 | |
| Disease | cognitive inhibition measurement | 2.04e-03 | 50 | 148 | 3 | EFO_0007969 | |
| Disease | Cirrhosis | 2.04e-03 | 50 | 148 | 3 | C1623038 | |
| Disease | Malformations of Cortical Development | 2.19e-03 | 14 | 148 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 2.19e-03 | 14 | 148 | 2 | C0431380 | |
| Disease | Autosomal recessive primary microcephaly | 2.51e-03 | 15 | 148 | 2 | cv:C3711387 | |
| Disease | Mouth Neoplasms | 2.54e-03 | 54 | 148 | 3 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 2.54e-03 | 54 | 148 | 3 | C0153381 | |
| Disease | vitamin C measurement | 2.86e-03 | 16 | 148 | 2 | EFO_0600003 | |
| Disease | response to acetylsalicylate | 2.86e-03 | 16 | 148 | 2 | GO_1903492 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 2.86e-03 | 16 | 148 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | neuroimaging measurement | AKT3 RELN TPCN2 MCPH1 SZT2 ITGB5 PTK2 PLEKHH3 ACAD11 PDGFD MTMR2 MACF1 HTT | 2.90e-03 | 1069 | 148 | 13 | EFO_0004346 |
| Disease | prostate cancer (is_implicated_in) | 2.91e-03 | 117 | 148 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | Huntington Disease | 3.23e-03 | 17 | 148 | 2 | C0020179 | |
| Disease | ischemia (implicated_via_orthology) | 3.23e-03 | 17 | 148 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma | 3.58e-03 | 124 | 148 | 4 | C0007137 | |
| Disease | PR interval | 3.62e-03 | 495 | 148 | 8 | EFO_0004462 | |
| Disease | parahippocampal gyrus volume measurement | 3.63e-03 | 18 | 148 | 2 | EFO_0010318 | |
| Disease | white matter microstructure measurement | 3.63e-03 | 390 | 148 | 7 | EFO_0005674 | |
| Disease | cystatin C measurement | 4.28e-03 | 402 | 148 | 7 | EFO_0004617 | |
| Disease | Coronary Arteriosclerosis | 4.30e-03 | 65 | 148 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 4.30e-03 | 65 | 148 | 3 | C1956346 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 4.47e-03 | 20 | 148 | 2 | DOID:3328 (is_marker_for) | |
| Disease | Global developmental delay | 4.59e-03 | 133 | 148 | 4 | C0557874 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.88e-03 | 68 | 148 | 3 | DOID:5419 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FRECTLETTVHASGW | 136 | Q9BXK5 | |
| RCLQWTTVIERTFHV | 76 | P31749 | |
| RCLQWTTVIERTFHV | 76 | P31751 | |
| TSRCEVQDRGVGWSH | 151 | P04003 | |
| SEDWVVTAAHCGVRT | 66 | Q6GPI1 | |
| EWLHRVVGDSRCTLV | 426 | Q9NUB1 | |
| GTSDRHIRIWNVCSG | 376 | Q12834 | |
| HQVSRVWRTDGLSSC | 306 | O60513 | |
| RVAWVSHDSTVCLAD | 216 | O15143 | |
| GRVEVKHADTWRSVC | 806 | Q9NR16 | |
| CSRTVESAHVQRAWE | 451 | P20711 | |
| DCRWVVVSTLRGTSH | 416 | Q9H6U6 | |
| LAVVLSSVSICDGHW | 36 | Q8WXS4 | |
| WAALLTDHCTVRVSG | 86 | Q2TAZ0 | |
| RVIAVLDWELSTIGH | 236 | Q709F0 | |
| CLQWTTVIERTFHVD | 76 | Q9Y243 | |
| CEENASRVWRLATGH | 1416 | Q9ULI1 | |
| RSHFEQWGTLTDCVV | 31 | Q32P51 | |
| SVTCVASWGGIVHLE | 6 | Q7Z3H0 | |
| TVQDESHSEWVSCVR | 141 | P63244 | |
| VVSSHWCEGTRRVVK | 26 | A8MUP6 | |
| WGVSVCTVDGQRHST | 261 | O94925 | |
| VLIHFWERLSEICVA | 486 | O94822 | |
| LQAIRKTVCDWETGH | 511 | Q7L576 | |
| LTECRVSISSLWAHT | 386 | P54762 | |
| HRKEERCSRVWGTTC | 336 | O95340 | |
| TVDHLCWRVGSDSHI | 466 | Q14667 | |
| TPRGWHCAVTLSDRV | 501 | Q9H511 | |
| VSVLWVEKCRTAGAH | 71 | Q8NEM0 | |
| GLNSTHIGEDRCRTW | 311 | Q6P1Q0 | |
| HRCVDESEGRLWAES | 141 | Q9NZQ0 | |
| TWRVRILSDGEHEQS | 1836 | Q5SZK8 | |
| HKGRRVTALCWDTAI | 121 | Q9UPZ3 | |
| WTTECENREAVTHIG | 166 | P06730 | |
| HLWSEGSDIQRVLCV | 251 | Q5H9U9 | |
| LHRIGDITSCSVLWL | 206 | Q969U6 | |
| ETSTIIRGRWCGHKE | 121 | Q9GZP0 | |
| GILWVNHREISSVGC | 81 | Q9Y5P1 | |
| VHRSWDCRISGVLAV | 696 | Q6ZU69 | |
| VHRSWDCRISGVLAV | 426 | Q63HN1 | |
| VHESNEVWCRCITTI | 176 | Q13324 | |
| TCITDLRTSHWEEAI | 66 | Q8TBE9 | |
| HCTWLVDTQDSRRVL | 281 | O75074 | |
| RWLLEERGTLTSHCS | 91 | Q96LR2 | |
| TSVVVHCSDGWDRTA | 411 | Q13614 | |
| VVVSRPGRDEALCWH | 526 | Q2VPB7 | |
| CHQTGLDRSTLISWT | 171 | P52790 | |
| TCHSLCRDEVITWVD | 656 | P18084 | |
| EWSSTHPRRCVTEGQ | 416 | Q9UBG3 | |
| SVSCIEVTPGDRSWH | 296 | Q96JZ2 | |
| RACHGTLIKWIEETT | 1281 | Q9UPN3 | |
| HTGDFEEWTRITIVI | 1361 | P78509 | |
| RSDSWHISLETAVGV | 186 | Q9UKJ1 | |
| IEPHTTCAWDSVTVR | 2736 | O60494 | |
| VWCSVRTPESSHEGL | 826 | P0DPD8 | |
| ICSILSRSRFHVGDW | 776 | P42858 | |
| TLSCFIDEHVTRVAW | 51 | A6NGN9 | |
| DWVVTAGHCISRDLT | 66 | P09093 | |
| WVQVGRTEVVRSSLH | 56 | Q9UBL6 | |
| VVTLLEDHEGCTWGV | 81 | Q9BUX1 | |
| RTLKVWNAETGECIH | 441 | Q969H0 | |
| ATLRVWDIETGQCLH | 481 | Q969H0 | |
| TSIRVWDVETGNCIH | 561 | Q969H0 | |
| EVTVAPVHICTSWES | 106 | P02741 | |
| PTIEGHWVSTGCEVR | 71 | Q8J025 | |
| DWVVTAGHCISSSRT | 66 | P08861 | |
| VLGIHPEAIRSCWET | 3091 | Q0VDD8 | |
| WEDALHTVRAGRSCA | 111 | Q9NRW4 | |
| TWSLRHSEDGICRIS | 366 | Q9HBG7 | |
| IWTHDGCALDTRRVS | 86 | A2RUH7 | |
| VRSVCWRGDHILVGT | 286 | Q05BV3 | |
| EDTVEWRHRNVESLC | 491 | Q9UKA1 | |
| RVVSWLVLVEGAHSD | 76 | P54792 | |
| VMVWTVGVCRHSVER | 391 | Q8WVV5 | |
| IIHLEGDCTSDTWII | 96 | P51530 | |
| AICLWDVLTGSRVSH | 1141 | Q12770 | |
| VTEWDLVCSHRALRQ | 121 | Q4U2R8 | |
| VTAEATHLRVGWAST | 686 | Q92736 | |
| WGADVVAESRHRLVV | 21 | Q494R4 | |
| SEDWVVTAAHCGVRT | 66 | P17538 | |
| CIAVTHLKARTGWER | 281 | Q9UK39 | |
| VRWCVVHGRLLSADT | 221 | Q7Z7J5 | |
| GISIHWRSSTVCSLD | 1191 | Q3ZCN5 | |
| LCDGRWHRITVIRDS | 1726 | Q16363 | |
| RCEVTVHWRALVGGL | 1131 | Q9H195 | |
| ERDILLIHSCRQWTT | 46 | Q75VX8 | |
| FLCGVTEVIHADRWT | 516 | Q9H611 | |
| FSCDVVWGTVIRVHS | 2036 | Q5T011 | |
| WDTTAGRCERILTGH | 231 | Q9NVX2 | |
| DRTIKVWRAHDGVLC | 266 | Q9NVX2 | |
| WSVTVSGRKHSVRLC | 166 | Q7Z736 | |
| VQSHCVIDERTDVWS | 206 | O75716 | |
| RHSWVNTTALITGCT | 106 | Q86TG1 | |
| LGAVAWCHVTTVTRL | 76 | Q8IW70 | |
| VCDRVERGTHFWLLV | 101 | Q9H7F4 | |
| WAGLVTTLCEGIRRH | 71 | Q17RQ9 | |
| TLCHLTQERERVWDT | 436 | Q9H4M7 | |
| CVHQGREVASGERWT | 1151 | Q6ZWJ8 | |
| WLPGSTVEHVARCRS | 106 | Q96ME1 | |
| TWASIIRHGDATDVR | 51 | Q05397 | |
| VFGHWDVVTCLARSE | 2716 | Q8NFP9 | |
| ITSDCGHTWRQVFEE | 546 | Q96PQ0 | |
| EVHLVRFCVRHSWGT | 836 | Q6ZUB1 | |
| DSTVRLWDVDRGICI | 421 | Q9BZK7 | |
| ATHCVLETTIWTHRV | 236 | Q67FW5 | |
| ETKTGADVCRLWRIH | 176 | Q86XI2 | |
| EEIIVCRWHDSSVVN | 406 | Q6P3X8 | |
| CSWSEVRDLTEEVIG | 136 | Q9UQ49 | |
| RQLSWEHGHVLCTSV | 126 | Q8TCW9 | |
| TVLRGHESEVFICAW | 226 | O60907 | |
| TVRLWDIERGVCTHT | 486 | O60907 | |
| ILETSRGADWRVAHV | 166 | Q9UBH6 | |
| ITCVDSGILRVWHDK | 101 | Q6RFH5 | |
| VSRSCTDEGWTHLEP | 101 | P32241 | |
| STTAHCQIRVWDVSG | 1181 | Q96KV7 | |
| DLCQKVTLTRHRSWG | 46 | Q5SXM1 | |
| IIVSGSRDRTCIIWD | 3141 | Q8IZQ1 | |
| VKVWDVGTRTCVHTF | 256 | Q9GZS3 | |
| VHLCWVRSGISRAAL | 566 | Q9NRA0 | |
| WVNSHLARVTCRVGD | 66 | O15020 | |
| VHICVSWESSSGIAE | 111 | P02743 | |
| TVRCSGQHWEREAAV | 146 | Q9HCN8 | |
| CVHLREIESRWQGTD | 46 | Q86UD0 | |
| RVEILHSGLWGTVCD | 201 | Q8WTU2 | |
| LWERLVHELDTTGEC | 321 | Q96N76 | |
| ETERVSERHGWVVQC | 1511 | Q15413 | |
| TCLAHCWVVVRLDGR | 46 | Q9NWX6 | |
| WTREHSSCAELTRLL | 226 | Q96PX9 | |
| EIDITDASVVRCLWH | 466 | Q9NW82 | |
| WTCGAHTEILAERTF | 871 | O95759 | |
| SCDDVITGRHWLARE | 61 | Q8TBR7 | |
| HRVGRWVTVRTQDVC | 151 | Q96FX7 | |
| VDTLHLCWRAVTPET | 356 | Q8IY51 | |
| SVLESCLHRWRTEIE | 546 | Q9UHP3 | |
| ATVVGDRWLLSAAHC | 531 | Q7Z410 | |
| DCGATWVVLGHSERR | 86 | P60174 | |
| TATWVLTAGHCISSR | 111 | Q7Z5A4 | |
| LVRERWVLTAAHCTK | 111 | Q86WS5 | |
| TEWDLGVCRESVHRK | 251 | O75678 | |
| WSHTNDTIGSVRRCI | 906 | O00507 | |
| CNHISSVRAVAVWGI | 771 | Q9NNW5 | |
| VWHAVLISRGETSIE | 286 | Q969W1 | |
| WIHSQLEAECLVGTS | 1456 | O43379 | |
| TELWVAERGTTQGCH | 81 | P17098 | |
| EECVSVWSHEGLVLT | 176 | Q86XT9 | |
| ALTCISRGSEAWIHS | 581 | Q8TEC5 | |
| VCGVSLLSHRWALTA | 66 | Q9Y6M0 | |
| SWRHVKTGCETVDAV | 491 | O94901 | |
| ERDHWRSGRTICIKT | 386 | Q2TBF2 | |
| SDDGTVRIWDFLRCH | 221 | Q9C0J8 | |
| DVTHSSNWILGVCRD | 346 | A6NLI5 | |
| RSHFEQWGTLTDCVV | 31 | P09651 | |
| RCSEVTHWVATEVLL | 471 | Q9UHV5 | |
| WEVRASDHSVTLGVS | 386 | Q6PJ69 | |
| SECDILHTLRWSSRL | 1031 | Q5T4S7 | |
| DWTVSLSLVCHEPLR | 171 | Q8NHX9 | |
| SVCLEPSAAVVWHVS | 161 | Q96DZ7 | |
| WRVTAEGDSHTEVVI | 236 | Q66K66 | |
| ETSNHLWLVVELCTG | 66 | Q96C45 | |
| TQILCSHLEGHRVTW | 686 | O76024 | |
| VTCGLLVASHWRREA | 81 | Q8NHV5 | |
| RSHAVWEHTTVLLTC | 161 | Q5VTT5 |